RecruitingNCT07414056

Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation


Sponsor

Ain Shams University

Enrollment

60 participants

Start Date

Nov 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients.


Eligibility

Min Age: 1 YearMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios for people with acute respiratory distress syndrome (ards). The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year to 12 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTNeutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07414056


Related Trials